# APi Group Corp: financial statements, quarterly

APG · NYSE · CIK 1796209 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/apg.md) · [Financials](/companies/apg/financials.md) · [Filings](/companies/apg/filings.md) · [Insiders](/companies/apg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/apg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,759 d](/filings/0001628280-26-011620.md) | [1,601](/filings/0001628280-25-021384.md) | [1,730](/filings/0001628280-25-036919.md) | [1,826](/filings/0001628280-25-047400.md) | [1,861 d](/filings/0001628280-26-011620.md) | [1,719](/filings/0001628280-26-028658.md) | [1,990](/filings/0001628280-26-051007.md) | [2,085](/filings/0001628280-26-068186.md) | [2,117 d](/filings/0001628280-26-011620.md) | [1,982](/filings/0001628280-26-028658.md) | [2,254](/filings/0001628280-26-051007.md) | [2,554](/filings/0001628280-26-068186.md) |
| Cost of revenue | $m | [1,251 d](/filings/0001628280-26-011620.md) | [1,109](/filings/0001628280-25-021384.md) | [1,186](/filings/0001628280-25-036919.md) | [1,259](/filings/0001628280-25-047400.md) | [1,286 d](/filings/0001628280-26-011620.md) | [1,177](/filings/0001628280-26-028658.md) | [1,375](/filings/0001628280-26-051007.md) | [1,433](/filings/0001628280-26-068186.md) | [1,439 d](/filings/0001628280-26-011620.md) | [1,362](/filings/0001628280-26-028658.md) | [1,551](/filings/0001628280-26-051007.md) | [1,784](/filings/0001628280-26-068186.md) |
| Gross profit | $m | [508 d](/filings/0001628280-26-011620.md) | [492](/filings/0001628280-25-021384.md) | [544](/filings/0001628280-25-036919.md) | [567](/filings/0001628280-25-047400.md) | [575 d](/filings/0001628280-26-011620.md) | [542](/filings/0001628280-26-028658.md) | [615](/filings/0001628280-26-051007.md) | [652](/filings/0001628280-26-068186.md) | [678 d](/filings/0001628280-26-011620.md) | [620](/filings/0001628280-26-028658.md) | [703](/filings/0001628280-26-051007.md) | [770](/filings/0001628280-26-068186.md) |
| Selling, general and administrative | $m | [433 d](/filings/0001628280-26-011620.md) | [392](/filings/0001628280-25-021384.md) | [418](/filings/0001628280-25-036919.md) | [425](/filings/0001628280-25-047400.md) | [459 d](/filings/0001628280-26-011620.md) | [458](/filings/0001628280-26-028658.md) | [472](/filings/0001628280-26-051007.md) | [489](/filings/0001628280-26-068186.md) | [514 d](/filings/0001628280-26-011620.md) | [517](/filings/0001628280-26-028658.md) | [528](/filings/0001628280-26-051007.md) | [568](/filings/0001628280-26-068186.md) |
| Operating income | $m | [75.0 d](/filings/0001628280-26-011620.md) | [100](/filings/0001628280-25-021384.md) | [126](/filings/0001628280-25-036919.md) | [142](/filings/0001628280-25-047400.md) | [116 d](/filings/0001628280-26-011620.md) | [84.0](/filings/0001628280-26-028658.md) | [143](/filings/0001628280-26-051007.md) | [163](/filings/0001628280-26-068186.md) | [164 d](/filings/0001628280-26-011620.md) | [103](/filings/0001628280-26-028658.md) | [175](/filings/0001628280-26-051007.md) | [202](/filings/0001628280-26-068186.md) |
| Interest expense | $m | [33.0 d](/filings/0001628280-24-007573.md) | [34.0](/filings/0001628280-24-019929.md) | not reported | not reported | not reported | [38.0](/filings/0001628280-26-028658.md) | [37.0](/filings/0001628280-26-051007.md) | [34.0](/filings/0001628280-26-068186.md) | not reported | [30.0](/filings/0001628280-26-028658.md) | [36.0](/filings/0001628280-26-051007.md) | [45.0](/filings/0001628280-26-068186.md) |
| Income tax | $m | [20.0 d](/filings/0001628280-26-011620.md) | [18.0](/filings/0001628280-25-021384.md) | [20.0](/filings/0001628280-25-036919.md) | [31.0](/filings/0001628280-25-047400.md) | [11.0 d](/filings/0001628280-26-011620.md) | [11.0](/filings/0001628280-26-028658.md) | [31.0](/filings/0001628280-26-051007.md) | [37.0](/filings/0001628280-26-068186.md) | [32.0 d](/filings/0001628280-26-011620.md) | [14.0](/filings/0001628280-26-028658.md) | [39.0](/filings/0001628280-26-051007.md) | [41.0](/filings/0001628280-26-068186.md) |
| Net income | $m | [25.0 d](/filings/0001628280-26-011620.md) | [45.0](/filings/0001628280-25-047400.md) | [69.0](/filings/0001628280-25-047400.md) | [69.0](/filings/0001628280-25-047400.md) | [67.0 d](/filings/0001628280-26-011620.md) | [35.0](/filings/0001628280-26-068186.md) | [77.0](/filings/0001628280-26-068186.md) | [93.0](/filings/0001628280-26-068186.md) | [97.0 d](/filings/0001628280-26-011620.md) | [57.0](/filings/0001628280-26-068186.md) | [99.0](/filings/0001628280-26-068186.md) | [114](/filings/0001628280-26-068186.md) |
| Diluted EPS | $ per share | not reported | [(1.34)](/filings/0001628280-25-021384.md) | [0.15](/filings/0001628280-25-036919.md) | [0.15](/filings/0001628280-25-047400.md) | not reported | [0.07](/filings/0001628280-26-028658.md) | [0.16](/filings/0001628280-26-051007.md) | [0.20](/filings/0001628280-26-068186.md) | not reported | [0.12](/filings/0001628280-26-028658.md) | [0.20](/filings/0001628280-26-051007.md) | [0.24](/filings/0001628280-26-068186.md) |
| Basic EPS | $ per share | not reported | [(1.34)](/filings/0001628280-25-021384.md) | [0.15](/filings/0001628280-25-036919.md) | [0.15](/filings/0001628280-25-047400.md) | not reported | [0.07](/filings/0001628280-26-028658.md) | [0.17](/filings/0001628280-26-051007.md) | [0.20](/filings/0001628280-26-068186.md) | not reported | [0.12](/filings/0001628280-26-028658.md) | [0.21](/filings/0001628280-26-051007.md) | [0.24](/filings/0001628280-26-068186.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001628280-25-008189.md) | [0.2](/filings/0001628280-24-019929.md) | [0.3](/filings/0001628280-24-033989.md) | [0.5](/filings/0001628280-24-044499.md) | [0.5](/filings/0001628280-26-011620.md) | [0.5](/filings/0001628280-25-021384.md) | [0.4](/filings/0001628280-25-036919.md) | [0.6](/filings/0001628280-25-047400.md) | [0.9](/filings/0001628280-26-068186.md) | [0.6](/filings/0001628280-26-028658.md) | [0.9](/filings/0001628280-26-051007.md) | [0.4](/filings/0001628280-26-068186.md) |
| Current assets | $bn | [2.6](/filings/0001628280-25-008189.md) | [2.2](/filings/0001628280-24-019929.md) | [2.5](/filings/0001628280-24-033989.md) | [2.7](/filings/0001628280-24-044499.md) | [2.7](/filings/0001628280-26-011620.md) | [2.6](/filings/0001628280-25-021384.md) | [2.8](/filings/0001628280-25-036919.md) | [3.0](/filings/0001628280-25-047400.md) | [3.2](/filings/0001628280-26-068186.md) | [3.0](/filings/0001628280-26-028658.md) | [3.5](/filings/0001628280-26-051007.md) | [3.4](/filings/0001628280-26-068186.md) |
| Total assets | $bn | [7.6](/filings/0001628280-25-008189.md) | [7.2](/filings/0001628280-24-019929.md) | [8.0](/filings/0001628280-24-033989.md) | [8.2](/filings/0001628280-24-044499.md) | [8.2](/filings/0001628280-26-011620.md) | [8.1](/filings/0001628280-25-021384.md) | [8.5](/filings/0001628280-25-036919.md) | [8.7](/filings/0001628280-25-047400.md) | [8.9](/filings/0001628280-26-068186.md) | [9.0](/filings/0001628280-26-028658.md) | [9.9](/filings/0001628280-26-051007.md) | [10.3](/filings/0001628280-26-068186.md) |
| Current liabilities | $bn | [1.8](/filings/0001628280-25-008189.md) | [1.7](/filings/0001628280-24-019929.md) | [1.7](/filings/0001628280-24-033989.md) | [1.8](/filings/0001628280-24-044499.md) | [1.9](/filings/0001628280-26-011620.md) | [1.8](/filings/0001628280-25-021384.md) | [1.9](/filings/0001628280-25-036919.md) | [2.0](/filings/0001628280-25-047400.md) | [2.2](/filings/0001628280-26-068186.md) | [2.1](/filings/0001628280-26-028658.md) | [2.5](/filings/0001628280-26-051007.md) | [2.9](/filings/0001628280-26-068186.md) |
| Total liabilities | $bn | [4.7](/filings/0001628280-25-008189.md) | [4.9](/filings/0001628280-24-019929.md) | [5.1](/filings/0001628280-24-033989.md) | [5.3](/filings/0001628280-24-044499.md) | [5.2](/filings/0001628280-26-011620.md) | [5.1](/filings/0001628280-25-021384.md) | [5.4](/filings/0001628280-25-036919.md) | [5.4](/filings/0001628280-25-047400.md) | [5.5](/filings/0001628280-26-068186.md) | [5.5](/filings/0001628280-26-028658.md) | [6.4](/filings/0001628280-26-051007.md) | [6.8](/filings/0001628280-26-068186.md) |
| Long-term debt | $bn | [2.3](/filings/0001628280-25-008189.md) | [2.6](/filings/0001628280-24-019929.md) | [2.8](/filings/0001628280-24-033989.md) | [2.8](/filings/0001628280-24-044499.md) | [2.7](/filings/0001628280-26-011620.md) | [2.8](/filings/0001628280-25-021384.md) | [2.8](/filings/0001628280-25-036919.md) | [2.8](/filings/0001628280-25-047400.md) | [2.8](/filings/0001628280-26-068186.md) | [2.8](/filings/0001628280-26-028658.md) | [3.2](/filings/0001628280-26-051007.md) | [3.2](/filings/0001628280-26-068186.md) |
| Current portion of debt | $bn | [0.0](/filings/0001628280-25-008189.md) | [0.1](/filings/0001628280-24-019929.md) | [0.0](/filings/0001628280-24-033989.md) | [0.0](/filings/0001628280-24-044499.md) | [0.0](/filings/0001628280-26-011620.md) | [0.0](/filings/0001628280-25-021384.md) | [0.0](/filings/0001628280-25-036919.md) | [0.0](/filings/0001628280-25-047400.md) | [0.0](/filings/0001628280-26-068186.md) | [0.0](/filings/0001628280-26-028658.md) | [0.3](/filings/0001628280-26-051007.md) | [0.4](/filings/0001628280-26-068186.md) |
| Shareholders' equity | $bn | [2.1](/filings/0001628280-26-011620.md) | [2.3](/filings/0001628280-25-047400.md) | [2.8](/filings/0001628280-25-047400.md) | [3.0](/filings/0001628280-25-047400.md) | [3.0](/filings/0001628280-26-068186.md) | [3.0](/filings/0001628280-26-068186.md) | [3.2](/filings/0001628280-26-068186.md) | [3.3](/filings/0001628280-26-068186.md) | [3.4](/filings/0001628280-26-068186.md) | [3.5](/filings/0001628280-26-068186.md) | [3.5](/filings/0001628280-26-068186.md) | [3.5](/filings/0001628280-26-068186.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [297 d](/filings/0001628280-26-011620.md) | [7.0](/filings/0001628280-25-021384.md) | [110 d](/filings/0001628280-25-036919.md) | [220 d](/filings/0001628280-25-047400.md) | [283 d](/filings/0001628280-26-011620.md) | [62.0](/filings/0001628280-26-028658.md) | [83.0 d](/filings/0001628280-26-051007.md) | [232 d](/filings/0001628280-26-068186.md) | [382 d](/filings/0001628280-26-011620.md) | [85.0](/filings/0001628280-26-028658.md) | [83.0 d](/filings/0001628280-26-051007.md) | [225 d](/filings/0001628280-26-068186.md) |
| Capital expenditure | $m | [22.0 d](/filings/0001628280-26-011620.md) | [22.0](/filings/0001628280-25-021384.md) | [22.0 d](/filings/0001628280-25-036919.md) | [22.0 d](/filings/0001628280-25-047400.md) | [18.0 d](/filings/0001628280-26-011620.md) | [12.0](/filings/0001628280-26-028658.md) | [27.0 d](/filings/0001628280-26-051007.md) | [31.0 d](/filings/0001628280-26-068186.md) | [26.0 d](/filings/0001628280-26-011620.md) | [18.0](/filings/0001628280-26-028658.md) | [31.0 d](/filings/0001628280-26-051007.md) | [27.0 d](/filings/0001628280-26-068186.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-26-011620.md) | [0.0](/filings/0001628280-25-021384.md) | [0.0 d](/filings/0001628280-25-036919.md) | [0.0 d](/filings/0001628280-25-047400.md) | [0.0 d](/filings/0001628280-26-011620.md) | [75.0](/filings/0001628280-26-028658.md) | [0.0 d](/filings/0001628280-26-051007.md) | [0.0 d](/filings/0001628280-26-068186.md) | [0.0 d](/filings/0001628280-26-011620.md) | [0.0](/filings/0001628280-26-028658.md) | [66.0 d](/filings/0001628280-26-051007.md) | [186 d](/filings/0001628280-26-068186.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [267](/filings/0001628280-24-019929.md) | [270](/filings/0001628280-24-033989.md) | [270](/filings/0001628280-24-044499.md) | [250](/filings/0001628280-25-021384.md) | [414](/filings/0001628280-25-036919.md) | [414](/filings/0001628280-25-047400.md) | [417](/filings/0001628280-26-028658.md) | [428](/filings/0001628280-26-051007.md) | [429](/filings/0001628280-26-068186.md) | [435](/filings/0001628280-26-028658.md) | [437](/filings/0001628280-26-051007.md) | [432](/filings/0001628280-26-068186.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 425,258,453 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0001628280-26-068186.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 15:38 ET. No prices; not investment advice.